Navigation Links
Adamis Pharmaceuticals Prevails in License Dispute Litigation
Date:2/28/2013

SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Adamis Pharmaceuticals Corporation (OTCQB: ADMP), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced that a court entered an order of dismissal with prejudice of a complaint filed against Adamis regarding a dispute over one of its license agreements, resolving the case in Adamis' favor.

As has been previously reported in the company's filings with the Securities and Exchange Commission, Cosmo Bioscience, Inc. et. al. v. Adamis Pharmaceuticals Corp. and Maurizio Zanetti was filed in San Diego Superior Court in May 2010.  Plaintiffs were affiliated Cosmo Bioscience entities that claimed to have sublicensed certain patented technology from Eurogen BV, an entity wholly owned and controlled by Maurizio Zanetti .  Plaintiffs claimed that Dr. Zanetti wrongfully terminated their license, and further that Dr. Zanetti, through Nevagen, LLC, another entity that he controlled, improperly licensed the same technology to Adamis in violation of the sublicense agreement with plaintiffs.  Plaintiffs asserted a single claim for declaratory relief seeking a declaration that the Cosmo sublicense was in full force and effect, and that the Adamis license was invalid.  The lawsuit was stayed in 2010, and the court ordered that the matter be arbitrated in the Italian courts pursuant to the arbitration provisions of the sublicense agreement.

In December 2012, Adamis and Dr. Zanetti filed motions to dismiss the lawsuit because of the plaintiffs' failure to proceed with arbitration.  The court heard the motions in February 2013 and entered an order dismissing the case because of the plaintiffs' failure
'/>"/>

SOURCE Adamis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
2. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
3. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
4. StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
5. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
6. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
7. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
8. Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March
9. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
10. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
11. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Los beneficios y ganancias están por ... gasto en investigación y desarrollo   En ... septiembre de 2014) ZEISS aumentó sus ingresos en un ... anterior: 4.190 millones de euros) a pesar de los ... un 14 por ciento, a 360 millones de euros. ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... KENNESAW, Ga. and RALEIGH, ... Clinical Trial Marketing Communications, LLC (CTMC), and Integrated ... in patient recruitment and retention for clinical trials ... called Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS ... and retention services to pharmaceutical, biotechnology and medical ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
...  InterMune, Inc. (NADSAQ: ITMN) today reported that ... its decision granting the additional benefit of ... of mild-to-moderate idiopathic pulmonary fibrosis (IPF).  Esbriet,s ... (not quantifiable benefit)  in the rating system ...
... Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China ... China, today announced financial results for the year ended December ... , Revenue increased 9% to $81.2 million in fiscal ... , Income from operations was $22.0 million in fiscal year ...
Cached Medicine Technology:Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 2Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 3Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 4Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 5Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA) 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 2China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 3China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 4China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 5China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 6China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 7China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 8China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 9China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 10China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 11China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results 12
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... pharmaceutical giant Cipla is holding talks with London based mining ... workers. About 11% of South African population is HIV positive, ... of being the country with the maximum number of HIV ... sure to have a devastating effect on the economy, and ...
... at London's Middlesex Hospital, advices passengers, who fly long haul flights, ... woman on board an airliner, while she was flying a long ... can be fatal to many people. ,Dr. Scurr says this ... that clot formation can also occur if a person spends long ...
... are happy you will live longer!!!! New research released ... framework makes a person healthy and prolongs life. These ... Alzheimer's disease in nuns. ,"It's been known for ... hostility can lead to illness," said David Snowdon, University ...
... have warned that the common white patches found inside the ... simple genetic test can help pinpoint if the patches could ... this research. If identified early and treated, leukoplakia, as the ... cancer prevented. ,The number of chromosomes in the cells ...
... Thakur, today warned doctors that their names could be removed ... if they were found guilty of indulging in female foeticide. ... nation-wide Census, which has come out with a disturbing picture ... the age of six. ,While there was slight improvement ...
... lumps are too small to be picked up by a ... potential candidate for breast cancer. But to offset this problem, ... headed by Dr. Saraswathi Sukumar, have devised a new method ... new method called ductal lavage. Ductal lavage, involves "washing" breast ...
Cached Medicine News:
Inquire...
... Captia™ Mumps IgG Enzyme- linked Immunosorbent Assay ... quantitative determination of IgG antibody to Mumps ... may be used for the determination of ... may be used to demonstrate seroconversion or ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... of the TEG analyzer and the TEG analytical ... the formation and dissolution of the clot, showing ... ,Haemoscope's TEG analyzer is the only hemostasis analyzer ... and proven model developed by Prof. Helmut Hartert ...
Medicine Products: